{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:51:47Z","timestamp":1793278307125,"version":"4.5.0"},"reference-count":45,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Primary Cutaneous Lymphomas in Croatia","award":["214-2180056-0052"],"award-info":[{"award-number":["214-2180056-0052"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatopathology"],"abstract":"<jats:p>Introduction: Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma, often exhibiting loss of pan-T-cell markers such as CD2, CD3, CD5, and CD7. While these immunophenotypic alterations assist in diagnosis, their prognostic relevance in early-stage MF remains uncertain. This study aimed to determine whether immunohistochemical loss of T-cell markers CD2, CD3, CD5, and CD7 in patients with early-stage mycosis fungoides is associated with overall survival and progression-free survival. Methods: This retrospective included 83 patients with stage IA\u2013IIA MF diagnosed between 2003 and 2012 at a single institution. Immunohistochemical staining of archived biopsy specimens was performed for CD2, CD3, CD5, and CD7. Loss of marker expression was defined as absence in \u226530% of lymphocytes. Clinical and histopathological data were correlated with survival and progression outcomes using Kaplan\u2013Meier curves and log-rank tests. Results: Loss of at least one T-cell marker was identified in 66% of patients, most commonly CD7 (72%), followed by CD5 (11%) and CD2 (11%). No cases showed loss of CD3 expression. CD7 loss was significantly associated with shorter progression-free survival (p &lt; 0.05), but not with overall survival. No significant associations were found between CD2 or CD5 loss and either survival or disease progression. Conclusions: CD7 loss was the only immunohistochemical abnormality significantly associated with earlier disease progression in early-stage MF, suggesting a potential prognostic role. In contrast, loss of CD2 and CD5 did not affect survival or progression, and CD3 was preserved in all cases. These findings highlight the value of incorporating CD7 status into prognostic assessment, although larger studies are needed to confirm its utility.<\/jats:p>","DOI":"10.3390\/dermatopathology12030029","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:14:55Z","timestamp":1757513695000},"page":"29","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Value of Immunohistochemical T-Cell Marker Loss in Early-Stage Mycosis Fungoides: A Single-Center Cohort Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-043X","authenticated-orcid":false,"given":"Sandra","family":"Jerkovic Gulin","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Ryhov County Hospital, 553 05 Jonkoping, Sweden"},{"name":"Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linkoping University, 581 83 Linkoping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-6684","authenticated-orcid":false,"given":"Ivana","family":"Ilic","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cytology, University Hospital Centre Zagreb, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8502-7816","authenticated-orcid":false,"given":"Dario","family":"Gulin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ryhov County Hospital, 553 05 Jonkoping, Sweden"},{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University, 581 83 Linkoping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-0149","authenticated-orcid":false,"given":"Georgios","family":"Kravvas","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University College London Hospitals NHS Foundation Trust, London NW1 2BU, UK"},{"name":"Department of Medicine, University College London, London NW1 2BU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Ceovic","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"ref_1","first-page":"504","article-title":"Mycosis fungoides: Disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"Geerts","year":"2000","journal-title":"Arch. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/11.suppl_1.S11","article-title":"EORTC classification for primary cutaneous lymphomas: A comparison with the R.E.A.L. Classification and the proposed WHO Classification","volume":"11","author":"Willemze","year":"2000","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"113343","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome\u2014Update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur. J. Cancer."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jdv.19987","article-title":"Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group","volume":"38","author":"Kempf","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000478-200001000-00005","article-title":"Efficacy of histologic criteria for diagnosing early mycosis fungoides: An EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer","volume":"24","author":"Santucci","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.pas.0000153121.57515.c6","article-title":"Histopathologic features of early (patch) lesions of mycosis fungoides: A morphologic study on 745 biopsy specimens from 427 patients","volume":"29","author":"Massone","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_8","first-page":"978","article-title":"Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections","volume":"11","author":"Izban","year":"1998","journal-title":"Mod. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0560.1998.tb01766.x","article-title":"Comparative analysis of histological and immunohistological features in mycosis fungoides and S\u00e9zary syndrome","volume":"25","author":"Kamarashev","year":"1998","journal-title":"J. Cutan. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2006.01.020","article-title":"CD4\/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: An immunohistochemical variant of mycosis fungoides","volume":"55","author":"Hodak","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0190-9622(86)70163-1","article-title":"Mycosis fungoides: Evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages","volume":"15","author":"Tosca","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-199206000-00002","article-title":"Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma","volume":"16","author":"Cerroni","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/Sezary syndrome: Clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: A study of 54 cases","volume":"130","author":"Laharanne","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1309\/3JK2H6Y988NUAY37","article-title":"Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates","volume":"125","author":"Florell","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/cup.12141","article-title":"Mycosis fungoides with reactive lymphoid follicles may represent an early histopathologic picture of granulomatous slack skin","volume":"40","author":"Ferrara","year":"2013","journal-title":"J. Cutan. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/030089161009600319","article-title":"B-cell lymphofollicular infiltrates in mycosis fungoides","volume":"96","author":"Ferrara","year":"2010","journal-title":"Tumori J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2133.1984.tb14146.x","article-title":"Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies","volume":"111","author":"Ralfkiaer","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/DAD.0b013e31825b26d1","article-title":"CD4\/CD8 double negative mycosis fungoides with PD-1 (CD279) expression\u2014A disease of follicular helper T-cells?","volume":"34","author":"Kempf","year":"2012","journal-title":"Am. J. Dermatopathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archdermatol.2012.1545","article-title":"Intertriginous mycosis fungoides: A distinct presentation of cutaneous T-cell lymphoma that may be caused by malignant follicular helper T cells","volume":"148","author":"Gammon","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/DAD.0b013e31827eaebd","article-title":"The difficulties in defining follicular T helper phenotype in cutaneous lymphomas","volume":"35","author":"Guitart","year":"2013","journal-title":"Am. J. Dermatopathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: An aggressive variant of cutaneous T-cell lymphoma","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0609.2006.00809.x","article-title":"Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides","volume":"78","author":"Hallermann","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.1711720110","article-title":"Primary cutaneous T-cell lymphoma: Clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma","volume":"172","author":"Beljaards","year":"1994","journal-title":"J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Aulasevich, N., Haist, M., F\u00f6rsch, S., Weidenthaler-Barth, B., and Mail\u00e4nder, V. (2022). The Role of the Immune Phenotype in Tumor Progression and Prognosis of Patients with Mycosis Fungoides: A Quantitative Immunohistology Whole Slide Approach. Cells, 11.","DOI":"10.3390\/cells11223570"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0560.2009.01381.x","article-title":"Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis","volume":"37","author":"Wada","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2133.2008.08504.x","article-title":"Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides","volume":"158","author":"Fujimura","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: Association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0002-9440(10)65372-2","article-title":"Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease","volume":"154","author":"Vermeer","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/DAD.0b013e31818ffbe8","article-title":"CD4+, CD56+ mycosis fungoides: Case report and review of the literature","volume":"31","author":"Horst","year":"2009","journal-title":"Am. J. Dermatopathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.jid.5700371","article-title":"Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma","volume":"126","author":"Tiemessen","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-0560.2007.00817.x","article-title":"CD20 positive mycosis fungoides: A case report","volume":"35","author":"Sen","year":"2008","journal-title":"J. Cutan. Pathol."},{"key":"ref_37","first-page":"269","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cup.12012","article-title":"Reactive lymphoid follicles with germinal centers in granulomatous mycosis fungoides: A case report with review of the literature","volume":"40","author":"Ishida","year":"2013","journal-title":"J. Cutan. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jdermsci.2013.04.020","article-title":"Prognostic factors in 105 Japanese cases of mycosis fungoides and S\u00e9zary syndrome: Clusterin expression as a novel prognostic factor","volume":"71","author":"Tobisawa","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2404482","article-title":"Improved reliability of lymphoma diagnostics via PCR-based clonality testing: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936","volume":"21","author":"Langerak","year":"2007","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cncr.34579","article-title":"Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study","volume":"129","author":"Allen","year":"2023","journal-title":"Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"Kim","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10428194.2013.790541","article-title":"Prognostic factors and risk stratification in early mycosis fungoides","volume":"55","author":"Vonderheid","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_44","first-page":"30","article-title":"Prognosis of primary cutaneous lymphomas","volume":"129","author":"Grange","year":"2002","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1067\/mjd.2001.116342","article-title":"Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: Implications for diagnosis of mycosis fungoides in community clinical practice","volume":"45","author":"Ormsby","year":"2001","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2296-3529\/12\/3\/29\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:43:27Z","timestamp":1760035407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2296-3529\/12\/3\/29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["dermatopathology12030029"],"URL":"https:\/\/doi.org\/10.3390\/dermatopathology12030029","relation":{},"ISSN":["2296-3529"],"issn-type":[{"value":"2296-3529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}